EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

PIK3R1 mutations in individuals with insulin resistance or growth retardation: Case series and in silico functional analysis

Tomofumi Takayoshi, Yushi Hirota iD, Aki Sugano, Kenji Sugawara iD, Takehito Takeuchi, Mika Ohta, Kai Yoshimura iD, Seiji Nishikage, Akane Yamamoto, Yu Mimura, Shinji Higuchi, Jun Mori und 4 weitere

Journal of Diabetes Investigation · 2025

DOI: 10.1111/jdi.70062 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Diabetes Investigation, 2025. Verfasst von Tomofumi Takayoshi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan. Hauptthemen laut MEDLINE: Class Ia Phosphatidylinositol 3-Kinase, Growth Disorders, Insulin Resistance, Limb Deformities, Congenital. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JSPS KAKENHI, Research Program for Intractable Disease of the Ministry of Health, Labor and Welfare of Japan, Research on Standardizing the Treatment of Rare Diseases Causing Diabetes Through the Creation of a Registry of the Japan Diabetes Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Introduction Phosphatidylinositol 3‐kinase (PI3K) plays a key role in insulin signaling, and mutations in PIK3R1 , which encodes a regulatory subunit (p85α) of this enzyme, are responsible for SHORT syndrome, which is associated with insulin‐resistant diabetes. We here describe four Japanese individuals from three families with SHORT syndrome who harbor either a common or a previously unknown mutation in PIK3R1 as well as provide an in silico functional analysis of the mutant proteins. Materials and Methods Gene sequencing was performed to identify PIK3R1 mutations. 3D structural analysis of wild‐type and mutant p85α proteins was performed by homology modeling, and structural optimization and molecular dynamics simulations confirmed stable trajectories. Docking simulations of p85α with a phosphopeptide were also conducted.

Results

We identified two families with a common mutation (c.1945C>T, p.R649W) and one family with a previously unidentified mutation (c.1957A>T, p.K653*) of PIK3R1 . In silico modeling revealed that both mutations impaired binding of p85α to phosphopeptide, with K653* resulting in the loss of amino acids that contribute to such binding. Docking simulations showed a significant loss of docking energy for the R649W mutant compared with the wild‐type protein ( P = 0.00329).

Conclusions

The four cases of SHORT syndrome were associated with early‐onset diabetes and intrauterine growth retardation, with the identified mutations likely disrupting the binding of p85α to phosphopeptide and thereby impairing insulin signaling. One case uniquely manifested diabetes without insulin resistance, emphasizing the need for further study of the clinical variability of SHORT syndrome, especially with regard to its associated diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Class Ia Phosphatidylinositol 3-KinaseGrowth DisordersInsulin ResistanceLimb Deformities, CongenitalMutationPhosphatidylinositol 3-KinasesHumansComputer SimulationMolecular Docking SimulationPedigreeHypercalcemiaMetabolic DiseasesNephrocalcinosis

Stichwörter der Autor:innen

In silico analysisInsulin resistance syndromePIK3R1 mutation

Substanzen

Class Ia Phosphatidylinositol 3-KinasePhosphatidylinositol 3-KinasesPIK3R1 protein, human

Autor:innen und Institutionen

  • Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Laboratory of Pharma-Medical Informatics and AI, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Division of Bioinformatics, Center for Advanced Antibody Drug Development, University of Toyama, Toyama, Japan.
  • Department of Medical Systems, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Department of Computational Drug Design and Mathematical Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Division of Pediatrics, Toyosato Hospital, Toyosato, Shiga, Japan.

ORCID-Profile: Yushi Hirota, Kenji Sugawara, Kai Yoshimura, Tohru Yorifuji, Wataru Ogawa

Förderung

  • JSPS KAKENHI
  • Research Program for Intractable Disease of the Ministry of Health, Labor and Welfare of Japan
  • Research on Standardizing the Treatment of Rare Diseases Causing Diabetes Through the Creation of a Registry of the Japan Diabetes Society

Zitieren

APA

Takayoshi, T., Hirota, Y., Sugano, A., Sugawara, K., Takeuchi, T., Ohta, M., Yoshimura, K., Nishikage, S., Yamamoto, A., Mimura, Y., Higuchi, S., Mori, J., Kawakita, R., Yorifuji, T., Takaoka, Y., & Ogawa, W. (2025). PIK3R1 mutations in individuals with insulin resistance or growth retardation: Case series and in silico functional analysis. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70062

Vancouver

Takayoshi T, Hirota Y, Sugano A, Sugawara K, Takeuchi T, Ohta M, et al. PIK3R1 mutations in individuals with insulin resistance or growth retardation: Case series and in silico functional analysis. Journal of Diabetes Investigation. 2025. doi:10.1111/jdi.70062

BibTeX
@article{Takayoshi2025,
  author = {Takayoshi, Tomofumi and Hirota, Yushi and Sugano, Aki and Sugawara, Kenji and Takeuchi, Takehito and Ohta, Mika and Yoshimura, Kai and Nishikage, Seiji and Yamamoto, Akane and Mimura, Yu and Higuchi, Shinji and Mori, Jun and Kawakita, Rie and Yorifuji, Tohru and Takaoka, Yutaka and Ogawa, Wataru},
  title = {PIK3R1 mutations in individuals with insulin resistance or growth retardation: Case series and in silico functional analysis},
  journal = {Journal of Diabetes Investigation},
  year = {2025},
  doi = {10.1111/jdi.70062}
}
Kostenlos starten →